Skip to main content
Watch Insiders

Corporate insider profile

Bihua Chen Insider Trades

Latest reported as Director / 10% Owner of BlossomHill Therapeutics, Inc. (BLSM).

Purchase filings
1
Reported companies
2
Net open-market value
-$4,785,124.50
Latest transaction
Aug 10, 2026

Affiliated corporations

Reported company relationships

BLSMLatest reported

BlossomHill Therapeutics, Inc.

Director / 10% Owner

DRUGPrior filing

BRIGHT MINDS BIOSCIENCES INC.

Corporate insider

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 10, 2026BlossomHill Therapeutics, Inc. (BLSM)Director / 10% OwnerOpen Market Purchase312,500$16.00$5,000,000
Apr 28, 2026BRIGHT MINDS BIOSCIENCES INC. (DRUG)Corporate insiderSale109,331$89.50$9,785,125